Neuroone Medical Technologies (NMTC) EPS (Diluted) Growth (1y) (2011 - 2026)
Neuroone Medical Technologies (NMTC) EPS (Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 95.96% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 114.19% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -29.80% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 35.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.89% |
| Dec 31, 2025 | -149.41% |
| Sep 30, 2025 | 67.79% |
| Jun 30, 2025 | 69.48% |
| Mar 31, 2025 | 33.77% |
| Dec 31, 2024 | 141.47% |
| Sep 30, 2024 | 27.64% |
| Jun 30, 2024 | 48.72% |
| Mar 31, 2024 | 48.66% |
| Dec 31, 2023 | -30.57% |
| Sep 30, 2023 | -101.40% |
| Jun 30, 2023 | -15.79% |
| Mar 31, 2023 | -13.62% |
| Dec 31, 2022 | 41.41% |
| Sep 30, 2022 | 91.98% |
| Jun 30, 2022 | 30.95% |
| Mar 31, 2022 | 11.33% |
| Dec 31, 2021 | 86.05% |
| Sep 30, 2021 | -114.53% |
| Jun 30, 2021 | 94.78% |